Literature DB >> 16314639

Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group.

Dirk Timmerman1, Antonia C Testa, Tom Bourne, Enrico Ferrazzi, Lieveke Ameye, Maja L Konstantinovic, Ben Van Calster, William P Collins, Ignace Vergote, Sabine Van Huffel, Lil Valentin.   

Abstract

PURPOSE: To collect data for the development of a more universally useful logistic regression model to distinguish between a malignant and benign adnexal tumor before surgery. PATIENTS AND METHODS: Patients had at least one persistent mass. More than 50 clinical and sonographic end points were defined and recorded for analysis. The outcome measure was the histologic classification of excised tissues as malignant or benign.
RESULTS: Data from 1,066 patients recruited from nine European centers were included in the analysis; 800 patients (75%) had benign tumors and 266 (25%) had malignant tumors. The most useful independent prognostic variables for the logistic regression model were as follows: (1) personal history of ovarian cancer, (2) hormonal therapy, (3) age, (4) maximum diameter of lesion, (5) pain, (6) ascites, (7) blood flow within a solid papillary projection, (8) presence of an entirely solid tumor, (9) maximal diameter of solid component, (10) irregular internal cyst walls, (11) acoustic shadows, and (12) a color score of intratumoral blood flow. The model containing all 12 variables (M1) gave an area under the receiver operating characteristic curve of 0.95 for the development data set (n = 754 patients). The corresponding value for the test data set (n = 312 patients) was 0.94; and a probability cutoff value of .10 gave a sensitivity of 93% and a specificity of 76%.
CONCLUSION: Because the model was constructed from multicenter data, it is more likely to be generally applicable. The effectiveness of the model will be tested prospectively at different centers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314639     DOI: 10.1200/JCO.2005.01.7632

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  68 in total

Review 1.  Triple-negative breast cancer: present challenges and new perspectives.

Authors:  Franca Podo; Lutgarde M C Buydens; Hadassa Degani; Riet Hilhorst; Edda Klipp; Ingrid S Gribbestad; Sabine Van Huffel; Hanneke W M van Laarhoven; Jan Luts; Daniel Monleon; Geert J Postma; Nicole Schneiderhan-Marra; Filippo Santoro; Hans Wouters; Hege G Russnes; Therese Sørlie; Elda Tagliabue; Anne-Lise Børresen-Dale
Journal:  Mol Oncol       Date:  2010-04-24       Impact factor: 6.603

Review 2.  Contemporary progress in ovarian cancer screening.

Authors:  Christine S Walsh; B Y Karlan
Journal:  Curr Oncol Rep       Date:  2007-11       Impact factor: 5.075

Review 3.  Transvaginal ultrasound assessment of the premenopausal ovarian mass.

Authors:  Leeber Cohen
Journal:  J Assist Reprod Genet       Date:  2007-11-16       Impact factor: 3.412

4.  An EEG-based machine learning method to screen alcohol use disorder.

Authors:  Wajid Mumtaz; Pham Lam Vuong; Likun Xia; Aamir Saeed Malik; Rusdi Bin Abd Rashid
Journal:  Cogn Neurodyn       Date:  2016-10-24       Impact factor: 5.082

5.  Assessing the discriminative ability of risk models for more than two outcome categories.

Authors:  Ben Van Calster; Yvonne Vergouwe; Caspar W N Looman; Vanya Van Belle; Dirk Timmerman; Ewout W Steyerberg
Journal:  Eur J Epidemiol       Date:  2012-10-07       Impact factor: 8.082

6.  Single-port-access, hand-assisted laparoscopic surgery for benign large adnexal tumors versus single-port pure laparoscopic surgery for adnexal tumors.

Authors:  Hyun-Jin Roh; Soo-Jeong Lee; Jun-Woo Ahn; Yong-Soon Kwon; Hyun-Jin Cho; Dae-Yeon Kim
Journal:  Surg Endosc       Date:  2011-10-25       Impact factor: 4.584

7.  Ultrasound-based logistic regression model LR2 versus magnetic resonance imaging for discriminating between benign and malignant adnexal masses: a prospective study.

Authors:  Kanane Shimada; Koji Matsumoto; Takashi Mimura; Tetsuya Ishikawa; Jiro Munechika; Yoshimitsu Ohgiya; Miki Kushima; Yusuke Hirose; Yuka Asami; Chiaki Iitsuka; Shingo Miyamoto; Mamiko Onuki; Hajime Tsunoda; Ryu Matsuoka; Kiyotake Ichizuka; Akihiko Sekizawa
Journal:  Int J Clin Oncol       Date:  2017-12-13       Impact factor: 3.402

8.  Coregistered photoacoustic and ultrasound imaging and classification of ovarian cancer: ex vivo and in vivo studies.

Authors:  Hassan S Salehi; Hai Li; Alex Merkulov; Patrick D Kumavor; Hamed Vavadi; Melinda Sanders; Angela Kueck; Molly A Brewer; Quing Zhu
Journal:  J Biomed Opt       Date:  2016-04-30       Impact factor: 3.170

9.  Polytomous diagnosis of ovarian tumors as benign, borderline, primary invasive or metastatic: development and validation of standard and kernel-based risk prediction models.

Authors:  Ben Van Calster; Lil Valentin; Caroline Van Holsbeke; Antonia C Testa; Tom Bourne; Sabine Van Huffel; Dirk Timmerman
Journal:  BMC Med Res Methodol       Date:  2010-10-20       Impact factor: 4.615

Review 10.  Evaluation of markers and risk prediction models: overview of relationships between NRI and decision-analytic measures.

Authors:  Ben Van Calster; Andrew J Vickers; Michael J Pencina; Stuart G Baker; Dirk Timmerman; Ewout W Steyerberg
Journal:  Med Decis Making       Date:  2013-01-11       Impact factor: 2.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.